Our proven executive team brings deep, diverse cell therapy and oncology experience and is committed to developing safe, effective, and accessible NK cell therapies for cancer. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.

Brian Daniels, M.D.

Chairman

Tom Farrell

President, CEO and Director

Yong-Jun Huh

Director

Laura Stoppel, Ph.D.

Director

Yu-Kyeong Hwang, Ph.D.

Director

Yvonne Yamanaka, Ph.D.

Director

 

Sign up for news updates

  • Twitter
  • LinkedIn

Privacy Policy  |  Terms
© Artiva Biotherapeutics, Inc., 2020